LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice

Hong-Xia Mei, Yang Ye, Hao-Ran Xu, Shu-Yang Xiang, Qian Yang, Hong-Yu Ma, Sheng-Wei Jin, Qian Wang Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, People’s Republic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mei HX, Ye Y, Xu HR, Xiang SY, Yang Q, Ma HY, Jin SW, Wang Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/fa63d4c6674b42a4a6f2844b65334c63
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa63d4c6674b42a4a6f2844b65334c63
record_format dspace
spelling oai:doaj.org-article:fa63d4c6674b42a4a6f2844b65334c632021-12-02T14:15:10ZLXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice1178-7031https://doaj.org/article/fa63d4c6674b42a4a6f2844b65334c632021-04-01T00:00:00Zhttps://www.dovepress.com/lxa4-inhibits-lipopolysaccharide-induced-inflammatory-cell-accumulatio-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Hong-Xia Mei, Yang Ye, Hao-Ran Xu, Shu-Yang Xiang, Qian Yang, Hong-Yu Ma, Sheng-Wei Jin, Qian Wang Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, People’s Republic of ChinaCorrespondence: Sheng-Wei Jin; Qian WangDepartment of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, 109 Xueyuan Road, Wenzhou, Zhejiang Province, 325027, People’s Republic of ChinaTel +86-577-88002806Fax +86-577-88832693Email jinshengwei69@163.com; wqian84@163.comIntroduction: Alveolar macrophages that regulate the inflammatory response in lungs are the main target cell for the treatment of inflammatory pulmonary pathologies, such as acute respiratory distress syndrome (ARDS). Yolk sac derived alveolar resident macrophages play an important role in the pulmonary inflammatory response. With regards to anti-inflammatory actions, lipoxin A4 (LXA4) has been identified as an inflammatory “braking signal”.Methods: In vivo, LXA4 (0.1 μg/mouse) was injected intraperitoneally after intratracheal (1 mg/kg) lipopolysaccharide (LPS) administration; flow cytometry was used to measure peripheral blood monocyte derived recruited macrophage and neutrophil numbers; resident alveolar macrophage was depleted by liposome clodronate; CXCL2, CCL2, MMP9 level was detected by RT-PCR and ELISA. In vitro, sorted resident macrophages (1× 106) were cultured with LPS (1 μg/mL) and LXA4 (100 nmol/mL) with or without BOC-2 (10 μM) for 24 h to gain a better understanding of the mechanisms of LXA4.Results: LXA4 inhibited tumor necrosis factor-a (TNF-a) and interleukin-1β (IL-1β) production induced by LPS. LXA4 also mediated LPS-induced macrophage recruitment and showed that this was dependent on CCL2 secretion and release by resident macrophages. LXA4 protects lung tissue by inhibiting neutrophil recruitment, partly through the CXCL2/MMP-9 signaling pathway. CXCL2 and MMP-9 are mainly expressed by resident macrophages and neutrophils, respectively. Finally, LXA4’s beneficial effects were abrogated by BOC-2, an LXA4 receptor inhibitor.Conclusion: These results suggest that LXA4 may be a promising therapy for preventing and treating ARDS.Keywords: resident macrophage, recruited macrophage, neutrophil, lipoxin A4, lipopolysaccharideMei HXYe YXu HRXiang SYYang QMa HYJin SWWang QDove Medical Pressarticleresident macrophagerecruited macrophageneutrophillipoxin a4lipopolysaccharidePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 1375-1385 (2021)
institution DOAJ
collection DOAJ
language EN
topic resident macrophage
recruited macrophage
neutrophil
lipoxin a4
lipopolysaccharide
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle resident macrophage
recruited macrophage
neutrophil
lipoxin a4
lipopolysaccharide
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Mei HX
Ye Y
Xu HR
Xiang SY
Yang Q
Ma HY
Jin SW
Wang Q
LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
description Hong-Xia Mei, Yang Ye, Hao-Ran Xu, Shu-Yang Xiang, Qian Yang, Hong-Yu Ma, Sheng-Wei Jin, Qian Wang Department of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, People’s Republic of ChinaCorrespondence: Sheng-Wei Jin; Qian WangDepartment of Anesthesia and Critical Care, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, 109 Xueyuan Road, Wenzhou, Zhejiang Province, 325027, People’s Republic of ChinaTel +86-577-88002806Fax +86-577-88832693Email jinshengwei69@163.com; wqian84@163.comIntroduction: Alveolar macrophages that regulate the inflammatory response in lungs are the main target cell for the treatment of inflammatory pulmonary pathologies, such as acute respiratory distress syndrome (ARDS). Yolk sac derived alveolar resident macrophages play an important role in the pulmonary inflammatory response. With regards to anti-inflammatory actions, lipoxin A4 (LXA4) has been identified as an inflammatory “braking signal”.Methods: In vivo, LXA4 (0.1 μg/mouse) was injected intraperitoneally after intratracheal (1 mg/kg) lipopolysaccharide (LPS) administration; flow cytometry was used to measure peripheral blood monocyte derived recruited macrophage and neutrophil numbers; resident alveolar macrophage was depleted by liposome clodronate; CXCL2, CCL2, MMP9 level was detected by RT-PCR and ELISA. In vitro, sorted resident macrophages (1× 106) were cultured with LPS (1 μg/mL) and LXA4 (100 nmol/mL) with or without BOC-2 (10 μM) for 24 h to gain a better understanding of the mechanisms of LXA4.Results: LXA4 inhibited tumor necrosis factor-a (TNF-a) and interleukin-1β (IL-1β) production induced by LPS. LXA4 also mediated LPS-induced macrophage recruitment and showed that this was dependent on CCL2 secretion and release by resident macrophages. LXA4 protects lung tissue by inhibiting neutrophil recruitment, partly through the CXCL2/MMP-9 signaling pathway. CXCL2 and MMP-9 are mainly expressed by resident macrophages and neutrophils, respectively. Finally, LXA4’s beneficial effects were abrogated by BOC-2, an LXA4 receptor inhibitor.Conclusion: These results suggest that LXA4 may be a promising therapy for preventing and treating ARDS.Keywords: resident macrophage, recruited macrophage, neutrophil, lipoxin A4, lipopolysaccharide
format article
author Mei HX
Ye Y
Xu HR
Xiang SY
Yang Q
Ma HY
Jin SW
Wang Q
author_facet Mei HX
Ye Y
Xu HR
Xiang SY
Yang Q
Ma HY
Jin SW
Wang Q
author_sort Mei HX
title LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
title_short LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
title_full LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
title_fullStr LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
title_full_unstemmed LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
title_sort lxa4 inhibits lipopolysaccharide-induced inflammatory cell accumulation by resident macrophages in mice
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/fa63d4c6674b42a4a6f2844b65334c63
work_keys_str_mv AT meihx lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT yey lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT xuhr lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT xiangsy lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT yangq lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT mahy lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT jinsw lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
AT wangq lxa4inhibitslipopolysaccharideinducedinflammatorycellaccumulationbyresidentmacrophagesinmice
_version_ 1718391760798875648